Full Text View
Tabular View
No Study Results Posted
Related Studies
Study of the Safety and Efficacy of Apadenoson for Detection of Myocardial Perfusion Defects Using SPECT MPI (ASPECT2)
This study has been terminated.
Study NCT01313572   Information provided by Forest Laboratories

First Received on March 4, 2011.   Last Updated on April 27, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Coronary Artery Disease
Additional conditions recognized in this trial
Coronary Disease
Myocardial Ischemia
More general conditions related to this trial
Arterial Occlusive Diseases
Arteriosclerosis
Cardiovascular Diseases
Heart Diseases
Vascular Diseases
Interventions listed in this trial
Apadenoson SPECT-MPI
Adenosine SPECT-MPI
Additional drug interventions recognized in this trial
Adenosine
More general drug interventions related to this trial
Analgesics
Anti-Arrhythmia Agents
Cardiovascular Agents
Central Nervous System Agents
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Sensory System Agents
Therapeutic Uses
Vasodilator Agents
Sponsors listed in this trial
Forest Laboratories
PPD


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services